Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Cardiología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 3
ClinicalTrials.gov
Randomised, Double-blind, Double-dummy, Parallel-group, Comparative Study of Salmeterol/FP 50/100mcg bd Inhalation Powder Via Diskus With Oral Montelukast (5mg QD) Chewable Tablets in Children 6-14 Years
INTERVENTIONAL
Inicio: 1 de oct de 2005
ID: NCT00328718
Completado
Fase 3
ClinicalTrials.gov
Long-term Extension, Multicentre, Multi-international Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg, 1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
INTERVENTIONAL
Inicio: 1 de jul de 2009
ID: NCT00910429
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Multi-Center, Multi-National Study for Evaluation of Efficacy and Safety of Edoxaban (DU-176b) Versus Warfarin In Subjects With Atrial Fibrillation - Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation (ENGAGE - AF TIMI - 48)
INTERVENTIONAL
Inicio: 1 de nov de 2008
ID: NCT00781391
Terminado
Fase 2
ClinicalTrials.gov
A Long-term, Multicenter, Single-arm, Open-label Extension of the SERENADE Study, to Assess the Safety and Efficacy of Macitentan in Subjects With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease
INTERVENTIONAL
Inicio: 7 de dic de 2018
ID: NCT03714815
Reclutando
Fase 2
ClinicalTrials.gov
A Phase IIb, Randomised, Multicentre, Double-Blind Study to Evaluate the Effect of Baxdrostat in Combination With Dapagliflozin Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure.
INTERVENTIONAL
Inicio: 5 de dic de 2025
ID: NCT07222917
Completado
Fase 4
ClinicalTrials.gov
A Multicenter, Randomized, Open Label, Parallel Group Study Comparing Pre-discharge and posT-discharge tReatment Initiation With LCZ696 in heArt Failure patieNtS With Reduced ejectIon-fracTion hospItalized for an Acute decOmpensation eveNt (ADHF)
INTERVENTIONAL
Inicio: 12 de feb de 2016
ID: NCT02661217
Terminado
ClinicalTrials.gov
Mobile Health to Prevent Progression of Pre-hypertension in Latin American Urban Settings
INTERVENTIONAL
Inicio: 1 de sept de 2011
ID: NCT01295216
Activo, no recluta
Fase 4
ClinicalTrials.gov
MEMENTO - A Phase 4, Single-arm, Open-label Clinical Study to Evaluate Mavacamten in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy to Assess the Impact on Myocardial Structure With Cardiac Magnetic Resonance Imaging (CMR)
INTERVENTIONAL
Inicio: 24 de ene de 2024
ID: NCT06112743
Completado
Fase 3
ClinicalTrials.gov
Clinical Utility of Amlodipine/Atorvastatin to Improve Concomitant Cardiovascular Risk Factors of Hypertension and Dyslipidemia
INTERVENTIONAL
Inicio: 1 de may de 2004
ID: NCT00143234
Completado
Fase 3
ClinicalTrials.gov
A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 Diabetes
INTERVENTIONAL
Inicio: 17 de ene de 2017
ID: NCT02692716
Completado
Fase 2
ClinicalTrials.gov
A Randomized Dose Ranging Study of Hexadecasaccharide Including Active Control, in Patients With Unstable Angina or Non-ST-Segment Elevation Myocardial Infarction Scheduled to Undergo Percutaneous Coronary Intervention (SHINE)
INTERVENTIONAL
Inicio: 1 de dic de 2004
ID: NCT00123565
Completado
Fase 2
ClinicalTrials.gov
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Dose-Ranging, Phase 2b Study of the Safety and Efficacy of Continuous 48-Hour Intravenous Infusions of BMS-986231 in Hospitalized Patients With Heart Failure and Impaired Systolic Function
INTERVENTIONAL
Inicio: 13 de ene de 2017
ID: NCT03016325
Completado
Fase 3
ClinicalTrials.gov
Randomized, Multinational, Double-blind Study, Comparing a High Loading Dose Regimen of Clopidogrel Versus Standard Dose in Patients With Unstable Angina or Myocardial Infarction Managed With an Early Invasive Strategy.
INTERVENTIONAL
Inicio: 1 de jun de 2006
ID: NCT00335452
Completado
Fase 3
ClinicalTrials.gov
A Randomized 8-week Double-blind, Parallel-group, Active-controlled, Multicenter Study to Evaluate Efficacy and Safety of LCZ696 200 mg in Comparison With Olmesartan 20 mg in Essential Hypertensive Patients Not Responsive to Olmesartan
INTERVENTIONAL
Inicio: 1 de sept de 2013
ID: NCT01876368
Terminado
Fase 3
ClinicalTrials.gov
Phase 3 Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel Group Evaluation Of The Efficacy, Safety, And Tolerability Of Bococizumab (Pf-04950615) In Reducing The Occurrence Of Major Cardiovascular Events In High Risk Subjects.
INTERVENTIONAL
Inicio: 29 de oct de 2013
ID: NCT01975376
Completado
Fase 3
ClinicalTrials.gov
A Phase III Multi-Center, Double-Blind, Randomized, Parallel Group, Placebo-Controlled Clinical Trial in High-Risk Type 2 Diabetes Mellitus (T2DM) Subjects With Coronary Artery Disease (CAD) to Determine Whether Bromodomain Extraterminal Domain (BET) Inhibition Treatment With RVX000222 Increases the Time to Major Adverse Cardiovascular Events (MACE)
INTERVENTIONAL
Inicio: 1 de nov de 2015
ID: NCT02586155
Completado
Fase 3
ClinicalTrials.gov
A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects Following Acute Coronary Syndrome to Compare the Incidence of Major Adverse Cardiovascular Events (MACE).
INTERVENTIONAL
Inicio: 1 de dic de 2009
ID: NCT01000727
Completado
Fase 3
ClinicalTrials.gov
Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Ularitide (Urodilatin) Intravenous Infusion in Patients Suffering From Acute Decompensated Heart Failure [TRUE-AHF]
INTERVENTIONAL
Inicio: 1 de jul de 2012
ID: NCT01661634
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-blind, Active-controlled Study to Evaluate the Effects of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction
INTERVENTIONAL
Inicio: 23 de nov de 2016
ID: NCT02884206
Completado
Fase 4
ClinicalTrials.gov
Hospitalization and Mortality in Iron Deficient, Anemic Patients With Chronic Kidney (CKD) and Heart Failure Receiving Intravenous Iron Therapy: A Five Year Follow-up From a Pilot Study
INTERVENTIONAL
Inicio: 1 de mar de 2006
ID: NCT02392910
Anterior
1
...
34
35
36
...
434
Siguiente
Filtros